Literature DB >> 18171216

Prevalence of seropositivity to spotted fever group rickettsiae and Anaplasma phagocytophilum in a large, demographically diverse US sample.

Paul C F Graf1, Jean-Paul Chretien, Lady Ung, Joel C Gaydos, Allen L Richards.   

Abstract

BACKGROUND: Most epidemiologic studies of tick-borne rickettsial diseases in the United States are small and have limited demographic scope, making broader risk assessment difficult.
METHODS: We conducted a seroprevalence study of spotted fever group rickettsiae and Anaplasma phagocytophilum, the agent of human granulocytic anaplasmosis. Specimens were selected randomly from the Department of Defense Serum Repository for 10,000 diverse military personnel at various stages in their careers who were serving with active duty status in 1997. Antibody testing included enzyme-linked immunosorbent assay for Rickettsia rickettsii and A. phagocytophilum, and Western blot confirmation for A. phagocytophilum. Risk factors were assessed using logistic regression.
RESULTS: Subjects were mostly male and young and were diverse ethnically and geographically. Spotted fever group rickettsiae seropositivity was 6.0% (95% confidence interval, 5.5%-6.4%). In univariable logistic regression, seroprevalence was significantly higher among older subjects, men (6.5%, compared with 3.3% among women), black individuals (8.7%, compared with 5.6% among white individuals), subjects from states with above-average Rocky Mountain spotted fever incidence, and subjects in ground combat specialties. Associations remained significant in multivariable analysis for age, sex, black versus white race, home state with high incidence, and ground combat specialty. Among 696 subjects with serum samples obtained within 7 days after entering the military, the rate of seropositivity was 3.4% (95% confidence interval, 2.1%-4.8%). Seroprevalence was nonsignificantly lower in men (3.4%, compared with 3.7% in women ) and in black individuals (3.4%, compared with 4.1% in white individuals). A. phagocytophilum seropositivity, as determined by by enzyme-linked immunosorbent assay and Western blot, was 2.6% and 0.11% (95% confidence interval, 0.05%-0.18%), respectively. Western blot seropositivity was not significantly associated with subject characteristics in univariable analysis.
CONCLUSIONS: Spotted fever group rickettsiae exposure was common and A. phagocytophilum exposure was rare in a US population with broad demographic diversity.

Entities:  

Mesh:

Year:  2008        PMID: 18171216     DOI: 10.1086/524018

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  26 in total

1.  Seroprevalence and Risk Factors for Rickettsia and Leptospira Infection in Four Ecologically Distinct Regions of Peru.

Authors:  Gabriela Salmon-Mulanovich; Mark P Simons; Carmen Flores-Mendoza; Steev Loyola; María Silva; Matthew Kasper; Hugo R Rázuri; Luis Enrique Canal; Mariana Leguia; Daniel G Bausch; Allen L Richards
Journal:  Am J Trop Med Hyg       Date:  2019-06       Impact factor: 2.345

2.  National Surveillance Data Show Increase in Spotted Fever Rickettsiosis: United States, 2016-2017.

Authors:  Kristen Nichols Heitman; Naomi A Drexler; Dena Cherry-Brown; Amy E Peterson; Paige A Armstrong; Gilbert J Kersh
Journal:  Am J Public Health       Date:  2019-05       Impact factor: 9.308

3.  Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts.

Authors:  Ana A Weil; Elinor L Baron; Catherine M Brown; Mark S Drapkin
Journal:  Mayo Clin Proc       Date:  2012-03       Impact factor: 7.616

4.  Rocky mountain spotted fever in the United States, 2000-2007: interpreting contemporary increases in incidence.

Authors:  John J Openshaw; David L Swerdlow; John W Krebs; Robert C Holman; Eric Mandel; Alexis Harvey; Dana Haberling; Robert F Massung; Jennifer H McQuiston
Journal:  Am J Trop Med Hyg       Date:  2010-07       Impact factor: 2.345

5.  Seroepidemiologic study of human infections with spotted fever group Rickettsiae in North Carolina.

Authors:  Meagan F Vaughn; Josie Delisle; Joey Johnson; Gaylen Daves; Carl Williams; Jodi Reber; Nicole L Mendell; Donald H Bouyer; William L Nicholson; Abelardo C Moncayo; Steven R Meshnick
Journal:  J Clin Microbiol       Date:  2014-09-03       Impact factor: 5.948

6.  Human Infections by Multiple Spotted Fever Group Rickettsiae in Tennessee.

Authors:  Josie Delisle; Nicole L Mendell; Annica Stull-Lane; Karen C Bloch; Donald H Bouyer; Abelardo C Moncayo
Journal:  Am J Trop Med Hyg       Date:  2016-03-28       Impact factor: 2.345

7.  Immunoproteomic profiling of Rickettsia parkeri and Rickettsia amblyommii.

Authors:  Walairat Pornwiroon; Apichai Bourchookarn; Christopher D Paddock; Kevin R Macaluso
Journal:  Ticks Tick Borne Dis       Date:  2015-07-22       Impact factor: 3.744

8.  Rickettsial Infections among Cats and Cat Fleas in Riverside County, California.

Authors:  Kristin E Mullins; Alice N Maina; Laura Krueger; Ju Jiang; Robert Cummings; Allan Drusys; Greg Williams; Major Dhillon; Allen L Richards
Journal:  Am J Trop Med Hyg       Date:  2018-05-31       Impact factor: 2.345

9.  High prevalence of Rickettsia africae variants in Amblyomma variegatum ticks from domestic mammals in rural western Kenya: implications for human health.

Authors:  Alice N Maina; Ju Jiang; Sylvia A Omulo; Sally J Cutler; Fredrick Ade; Eric Ogola; Daniel R Feikin; M Kariuki Njenga; Sarah Cleaveland; Solomon Mpoke; Zipporah Ng'ang'a; Robert F Breiman; Darryn L Knobel; Allen L Richards
Journal:  Vector Borne Zoonotic Dis       Date:  2014-10       Impact factor: 2.133

10.  Serological and Molecular Evidence of Patients Infected with Anaplasma phagocytophilum in Mexico.

Authors:  Carolina Guadalupe Sosa-Gutierrez; Maria Almudena Cervantes-Castillo; Ramon Laguna-Gonzalez; Laura Yareli Lopez-Echeverria; Deyanira Ojeda-Ramírez; Mayra Oyervides
Journal:  Diseases       Date:  2021-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.